# BELLICUM PHARMACEUTICALS INC (BLCM)

> Institutional ownership reported to the SEC as of Q2 2023, from Form 13F filings. Source: https://holderbook.com/stocks/BLCM/

- Reporting holders: 4
- Reported value: $173.5K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Boxer Capital, LLC](https://holderbook.com/funds/1465837-boxer-capital-llc/) | $167.0K | 450,000 | 0.0% | 1 |
| [B. Riley Wealth Advisors, Inc.](https://holderbook.com/funds/1464811-b-riley-wealth-advisors-inc/) | $4.2K | 11,420 | 0.0% | 1 |
| [Tekla Capital Management LLC](https://holderbook.com/funds/1300336-tekla-capital-management-llc/) | $2.2K | 6,000 | 0.0% | 14 |
| [Princeton Global Asset Management LLC](https://holderbook.com/funds/1767349-princeton-global-asset-management-llc/) | $37 | 100 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2023 | 4 | $173.5K |
| Q1 2023 | 22 | $470.4K |
| Q4 2022 | 30 | $1.2M |
| Q3 2022 | 22 | $2.1M |
| Q2 2022 | 23 | $2.2M |
| Q1 2022 | 23 | $3.8M |
| Q4 2021 | 18 | $2.2M |
| Q3 2021 | 22 | $4.5M |
| Q2 2021 | 24 | $5.1M |
| Q1 2021 | 23 | $5.1M |
| Q4 2020 | 27 | $5.8M |
| Q3 2020 | 18 | $6.7M |